We are live on ! Find out more
RNXT icon

RenovoRx
RNXT

17 hedge funds and large institutions have $1.01M invested in RenovoRx in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 1

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

129% more capital invested

Capital invested by funds: $442K → $1.01M (+$570K)

70% more funds holding

Funds holding: 10 → 17 (+7)

0.65% more ownership

Funds ownership: 3.08% → 3.74% (+0.65%)

Holders
17
Holders Change
+7
Holders Change %
+70%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
4
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACM
ADAR1 Capital Management
Texas
+$436K
2
Millennium Management
Millennium Management
New York
+$106K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$94.4K
4
Citadel Advisors
Citadel Advisors
Florida
+$32.2K
5
HF
HRT Financial
New York
+$14.4K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$14.3K
2
Wells Fargo
Wells Fargo
California
-$92

RNXT Hedge Fund Activity: Q2 2024 in Review

17 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in RenovoRx (RNXT) for Q2 2024, worth a combined $1.01M — up 129% from $442K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new RNXT positions and 1 closed out — a net gain of 7 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was ADAR1 Capital Management, opening a new position worth an estimated $436K. The largest seller was BlackRock, cutting an estimated $14.3K.

  • 17 institutional investors held RenovoRx (RNXT) as of Q2 2024, up from 10 in Q1 2024.
  • Funds reported $1.01M of RenovoRx stock for Q2 2024, up 129% quarter-over-quarter.
  • 8 funds opened new RenovoRx positions in Q2 2024 and 1 closed out, a net change of +7 holders.
  • The largest RenovoRx buyer in Q2 2024 was ADAR1 Capital Management, an estimated $436K added.
  • The largest RenovoRx seller in Q2 2024 was BlackRock, an estimated $14.3K sold.

Based on aggregated 13F filings for Q2 2024.